Bill Nygren - Harris Associates L P
Holding/activity history for Regeneron Pharmaceuticals (REGN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q2 | 878 | <0.01 | Reduce 53.45% | <0.01 | $718.54 | $630,878 | SEC |
| 2023 Q1 | 1,886 | <0.01 | Reduce 97.90% | 0.13 | $821.67 | $1,549,670 | SEC |
| 2022 Q4 | 89,639 | 0.13 | Reduce 52.36% | 0.15 | $721.49 | $64,673,642 | SEC |
| 2022 Q3 | 188,176 | 0.28 | Reduce 67.70% | 0.47 | $688.87 | $129,629,000 | SEC |
| 2022 Q2 | 582,626 | 0.69 | Reduce 46.70% | 0.57 | $591.13 | $344,408,000 | SEC |
| 2022 Q1 | 1,093,017 | 1.23 | Reduce 17.28% | 0.22 | $698.42 | $763,385,000 | SEC |
| 2021 Q4 | 1,321,319 | 1.30 | Reduce 0.38% | <0.01 | $631.52 | $834,439,000 | SEC |
| 2021 Q3 | 1,326,296 | 1.28 | Reduce 8.22% | 0.11 | $605.18 | $802,648,000 | SEC |
| 2021 Q2 | 1,445,053 | 1.29 | Add 39.81% | 0.37 | $558.54 | $807,120,000 | SEC |
| 2021 Q1 | 1,033,578 | 0.84 | Add 95.71% | 0.41 | $473.14 | $489,027,000 | SEC |
| 2020 Q4 | 528,130 | 0.49 | Reduce 20.74% | 0.19 | $483.11 | $255,145,000 | SEC |
| 2020 Q3 | 666,295 | 0.91 | Reduce 45.71% | 0.85 | $559.78 | $372,979,000 | SEC |
| 2020 Q2 | 1,227,221 | 1.86 | Reduce 47.03% | 1.47 | $623.65 | $765,357,000 | SEC |
| 2020 Q1 | 2,317,018 | 3.13 | Reduce 46.94% | 1.37 | $488.29 | $1,131,377,000 | SEC |
| 2019 Q4 | 4,366,846 | 2.91 | Add 5.44% | 0.15 | $375.48 | $1,639,663,000 | SEC |
| 2019 Q3 | 4,141,452 | 2.23 | Add 5.79% | 0.12 | $277.40 | $1,148,839,000 | SEC |
| 2019 Q2 | 3,914,719 | 2.25 | Add 46.79% | 0.72 | $313.00 | $1,225,307,000 | SEC |
| 2019 Q1 | 2,666,971 | 2.01 | Reduce 11.44% | 0.26 | $410.62 | $1,095,112,000 | SEC |
| 2018 Q4 | 3,011,408 | 2.27 | Reduce 5.11% | 0.10 | $373.50 | $1,124,761,000 | SEC |
| 2018 Q3 | 3,173,644 | 2.02 | Add 0.79% | 0.02 | $404.04 | $1,282,279,000 | SEC |
| 2018 Q2 | 3,148,677 | 1.76 | Add 85.21% | 0.81 | $344.99 | $1,086,262,000 | SEC |
| 2018 Q1 | 1,700,033 | 0.99 | Buy | 0.99 | $344.36 | $585,423,000 | SEC |